Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
3,062
Views
74
CrossRef citations to date
0
Altmetric
Original Articles

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library

Jie FengDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Ting WangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Wanliang ShiDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Shuo ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
David SullivanDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Paul G AuwaerterFisher Center for Environmental Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
&
Ying ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USACorrespondence[email protected]
 show all
Pages 1-8 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

Citations (74)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Venkata Raveendra Pothineni, Dhananjay Wagh, Mustafeez Mujtaba Babar, Mohammed Inayathullah, David Solow-Cordero, Kwang-Min Kim, Aneesh V Samineni, Mansi B Parekh, Lobat Tayebi & Jayakumar Rajadas. (2016) Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening. Drug Design, Development and Therapy 10, pages 1307-1322.
Read now
Wei Sun, Rebecca A Weingarten, Miao Xu, Noel Southall, Sheng Dai, Paul Shinn, Philip E Sanderson, Peter R Williamson, Karen M Frank & Wei Zheng. (2016) Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria. Emerging Microbes & Infections 5:1, pages 1-11.
Read now
Jie Feng, Wanliang Shi, Shuo Zhang & Ying Zhang. (2015) Persister mechanisms in Borrelia burgdorferi: implications for improved intervention. Emerging Microbes & Infections 4:1, pages 1-1.
Read now
Jie Feng, Wanliang Shi, Shuo Zhang & Ying Zhang. (2015) Persister mechanisms in Borrelia burgdorferi: implications for improved intervention. Emerging Microbes & Infections 4:1, pages 1-3.
Read now
Jie Feng, Wanliang Shi, Shuo Zhang & Ying Zhang. (2015) Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection. Emerging Microbes & Infections 4:1, pages 1-15.
Read now

Articles from other publishers (69)

Yasir Alruwaili, Mary B. Jacobs, Nicole R. Hasenkampf, Amanda C. Tardo, Celine E. McDaniel & Monica E. Embers. (2023) Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease. Frontiers in Microbiology 14.
Crossref
Samuel M. Shor & Sunjya K. Schweig. (2023) The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses. Microorganisms 11:7, pages 1759.
Crossref
Heather Adkison & Monica E. Embers. (2023) Lyme disease and the pursuit of a clinical cure. Frontiers in Medicine 10.
Crossref
Neetu Dayal, Kenneth I. Onyedibe, Whitney M. Gribble & Herman O. Sintim. (2022) Membrane acting Povarov-Doebner derived compounds potently disperse preformed multidrug resistant Gram-positive bacterial biofilms. European Journal of Medicinal Chemistry 240, pages 114550.
Crossref
Richard I. Horowitz & Phyllis R. Freeman. (2022) Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review. Antibiotics 11:7, pages 912.
Crossref
Felipe C. Cabello, Monica E. Embers, Stuart A. Newman & Henry P. Godfrey. (2022) Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes. mBio 13:3.
Crossref
Piret Saar-Reismaa, Olga Bragina, Maria Kuhtinskaja, Indrek Reile, Pille-Riin Laanet, Maria Kulp & Merike Vaher. (2022) Extraction and Fractionation of Bioactives from Dipsacus fullonum L. Leaves and Evaluation of Their Anti-Borrelia Activity. Pharmaceuticals 15:1, pages 87.
Crossref
Björn E. Lindström, Barbro H. Skogman, Annika K. Lindström, Leif Tallstedt & Kenneth Nilsson. (2022) <b><i>Borrelia</i></b> Ocular Infection: A Case Report and a Systematic Review of Published Cases. Ophthalmic Research 65:2, pages 121-130.
Crossref
Alain Trautmann. (2021) La fatigue chronique, un symptôme trop souvent négligé. médecine/sciences 37:10, pages 910-919.
Crossref
Jason R. Bobe, Brandon L. Jutras, Elizabeth J. Horn, Monica E. Embers, Allison Bailey, Robert L. Moritz, Ying Zhang, Mark J. Soloski, Richard S. Ostfeld, Richard T. Marconi, John Aucott, Avi Ma'ayan, Felicia Keesing, Kim Lewis, Choukri Ben Mamoun, Alison W. Rebman, Mecaila E. McClune, Edward B. Breitschwerdt, Panga Jaipal Reddy, Ricardo Maggi, Frank Yang, Bennett Nemser, Aydogan Ozcan, Omai Garner, Dino Di Carlo, Zachary Ballard, Hyou-Arm Joung, Albert Garcia-Romeu, Roland R. Griffiths, Nicole Baumgarth & Brian A. Fallon. (2021) Recent Progress in Lyme Disease and Remaining Challenges. Frontiers in Medicine 8.
Crossref
Bijaya Sharma, Julie E McCarthy, Cecily A Freliech, Morgen M Clark & Linden T Hu. (2021) Genetic Background Amplifies the Effect of Immunodeficiency in Antibiotic Efficacy Against Borrelia burgdorferi . The Journal of Infectious Diseases 224:2, pages 345-350.
Crossref
Yabin Zhang, Weihua Fan, Chunhong Shao, Jiajia Wang, Yan Jin, Jing Shao, Ying Zhang & Yong Wang. (2021) Rapid Determination of Antibiotic Resistance in Klebsiella pneumoniae by a Novel Antibiotic Susceptibility Testing Method Using SYBR Green I and Propidium Iodide Double Staining. Frontiers in Microbiology 12.
Crossref
Richard I. Horowitz, Krithika Murali, Gauri Gaur, Phyllis R. Freeman & Eva Sapi. (2020) Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi. BMC Research Notes 13:1.
Crossref
Xiaoyan Zheng, Xiao Ma, Tingting Li, Wanliang Shi & Ying Zhang. (2020) Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro. BMC Microbiology 20:1.
Crossref
Elena Zayko, Dagmara Bataeva, Yuliya Yushina, Anzhelika Makhova & Mariya Grudistova. (2020) Flow cytometry as a rapid test for detection of tetracycline resistance directly in bacterial cells in Micrococcus luteus. Potravinarstvo Slovak Journal of Food Sciences 14, pages 954-959.
Crossref
Richard I. Horowitz & Phyllis R. Freeman. (2020) Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review. Antibiotics 9:11, pages 725.
Crossref
Hector Alvarez-Manzo, Yumin Zhang, Wanliang Shi & Ying Zhang. (2020) Evaluation of Disulfiram Drug Combinations and Identification of Other More Effective Combinations against Stationary Phase Borrelia burgdorferi. Antibiotics 9:9, pages 542.
Crossref
Nevena Zubcevik, Charlotte Mao, Qing Mei Wang, Eliezer L. Bose, Rose Nadlyne Octavien, David Crandell & Lisa J. Wood. (2020) Symptom Clusters and Functional Impairment in Individuals Treated for Lyme Borreliosis. Frontiers in Medicine 7.
Crossref
Jason P. Torres, Alireza G. Senejani, Gauri Gaur, Michael Oldakowski, Krithika Murali & Eva Sapi. (2020) Ex Vivo Murine Skin Model for B. burgdorferi Biofilm. Antibiotics 9:9, pages 528.
Crossref
Jesus Enrique Salcedo-Sora & Douglas B. Kell. (2020) A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery. Antibiotics 9:8, pages 508.
Crossref
Venkata Raveendra Pothineni, Hari-Hara S. K. Potula, Aditya Ambati, Venkata Vamsee Aditya Mallajosyula, Brindha Sridharan, Mohammed Inayathullah, Mohamed Sohail Ahmed & Jayakumar Rajadas. (2020) Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31. Scientific Reports 10:1.
Crossref
Martin Strnad, Libor Grubhoffer & Ryan O.M. Rego. (2020) Novel targets and strategies to combat borreliosis. Applied Microbiology and Biotechnology 104:5, pages 1915-1925.
Crossref
Alison W. Rebman & John N. Aucott. (2020) Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease. Frontiers in Medicine 7.
Crossref
Jie Feng, Jacob Leone, Sunjya Schweig & Ying Zhang. (2020) Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi. Frontiers in Medicine 7.
Crossref
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 273 326 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 235 270 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 222 234 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 187 221 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 158 186 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 99 157 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 65 98 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 27 64 .
Abigail A. Dumes. 2020. Divided Bodies. Divided Bodies 1 25 .
Loutfy H. Madkour. 2020. Reactive Oxygen Species (ROS), Nanoparticles, and Endoplasmic Reticulum (ER) Stress-Induced Cell Death Mechanisms. Reactive Oxygen Species (ROS), Nanoparticles, and Endoplasmic Reticulum (ER) Stress-Induced Cell Death Mechanisms 693 727 .
Vladimir V. Bamm, Jordan T. Ko, Iain L. Mainprize, Victoria P. Sanderson & Melanie K. B. Wills. (2019) Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums. Pathogens 8:4, pages 299.
Crossref
Samuel Shor, Christine Green, Beatrice Szantyr, Steven Phillips, Kenneth Liegner, Joseph BurrascanoJr.Jr., Robert Bransfield & Elizabeth L. Maloney. (2019) Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group. Antibiotics 8:4, pages 269.
Crossref
Xiao Ma, Wanliang Shi & Ying Zhang. (2019) Essential Oils with High Activity against Stationary Phase Bartonella henselae. Antibiotics 8:4, pages 246.
Crossref
Petra Jusková, Yannick R. F. Schmid, Ariane Stucki, Steven Schmitt, Martin Held & Petra S. Dittrich. (2019) “Basicles”: Microbial Growth and Production Monitoring in Giant Lipid Vesicles. ACS Applied Materials & Interfaces 11:38, pages 34698-34706.
Crossref
Kenneth B. Liegner. (2019) Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases. Antibiotics 8:2, pages 72.
Crossref
Tingting Li, Jie Feng, Shuzhen Xiao, Wanliang Shi, David Sullivan & Ying Zhang. (2019) Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae. Antibiotics 8:2, pages 50.
Crossref
Enea Gino Di Domenico, Ilaria Cavallo, Valentina Bordignon, Giovanna D'Agosto, Martina Pontone, Elisabetta Trento, Maria Teresa Gallo, Grazia Prignano, Fulvia Pimpinelli, Luigi Toma & Fabrizio Ensoli. (2018) The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis. Frontiers in Neurology 9.
Crossref
Ryan P. Trombetta, Paul M. Dunman, Edward M. Schwarz, Stephen L. Kates & Hani A. Awad. (2018) A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants. mSphere 3:5.
Crossref
Jie Feng, Wanliang Shi, Judith Miklossy, Genevieve Tauxe, Conor McMeniman & Ying Zhang. (2018) Identification of Essential Oils with Strong Activity against Stationary Phase Borrelia burgdorferi. Antibiotics 7:4, pages 89.
Crossref
Jie Feng, Rebecca Yee, Shuo Zhang, Lili Tian, Wanliang Shi, Wen-Hong Zhang & Ying Zhang. (2018) A Rapid Growth-Independent Antibiotic Resistance Detection Test by SYBR Green/Propidium Iodide Viability Assay. Frontiers in Medicine 5.
Crossref
S. Saputo, R. C. Faustoferri & R. G. QuiveyJr.Jr.. (2018) A Drug Repositioning Approach Reveals that Streptococcus mutans Is Susceptible to a Diverse Range of Established Antimicrobials and Nonantibiotics. Antimicrobial Agents and Chemotherapy 62:1.
Crossref
Sanjie Caol, Thomas Divers, Mark Crisman & Yung-Fu Chang. (2017) In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease. BMC Veterinary Research 13:1.
Crossref
Kayla Socarras, Priyanka Theophilus, Jason Torres, Khusali Gupta & Eva Sapi. (2017) Antimicrobial Activity of Bee Venom and Melittin against Borrelia burgdorferi. Antibiotics 6:4, pages 31.
Crossref
Jie Feng, Shuo Zhang, Wanliang Shi, Nevena Zubcevik, Judith Miklossy & Ying Zhang. (2017) Selective Essential Oils from Spice or Culinary Herbs Have High Activity against Stationary Phase and Biofilm Borrelia burgdorferi. Frontiers in Medicine 4.
Crossref
Felipe C. Cabello, Henry P. Godfrey, Julia V. Bugrysheva & Stuart A. Newman. (2017) Sleeper cells: the stringent response and persistence in the Borreliella ( Borrelia ) burgdorferi enzootic cycle . Environmental Microbiology 19:10, pages 3846-3862.
Crossref
A. Goc, A. Niedzwiecki & M. Rath. (2017) Reciprocal cooperation of phytochemicals and micronutrients against typical and atypical forms of Borrelia sp. . Journal of Applied Microbiology 123:3, pages 637-650.
Crossref
Bram Van den Bergh, Maarten Fauvart & Jan Michiels. (2017) Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiology Reviews 41:3, pages 219-251.
Crossref
Hermann A.M. Mucke. (2017) Drug Repurposing Patent Applications January–March 2017. ASSAY and Drug Development Technologies 15:3, pages 127-132.
Crossref
Jie Feng, Shuo Zhang, Wanliang Shi & Ying Zhang. (2017) Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro. Antibiotics 6:1, pages 10.
Crossref
Venkata Raveendra Pothineni, Dhananjay Wagh, Mustafeez Mujtaba Babar, Mohammed Inayathullah, R Edward Watts, Kwang-Min Kim, Mansi B Parekh, Abhijit Achyut Gurjarpadhye, David Solow-Cordero, Lobat Tayebi & Jayakumar Rajadas. (2016) Screening of NCI-DTP library to identify new drug candidates for Borrelia burgdorferi. The Journal of Antibiotics 70:3, pages 308-312.
Crossref
Tomasz Chmielewski & Stanisława Tylewska-Wierzbanowska. (2017) Susceptibility of spirochetes Borreliaburgdorferi sensulato to antibiotics in vitro . Postępy Mikrobiologii - Advancements of Microbiology 56:3, pages 335-339.
Crossref
John N. Aucott & Benjamin J. Luft. 2017. Infectious Diseases. Infectious Diseases 405 414.e3 .
Douglas H. Nakahata, Wilton R. Lustri, Alexandre Cuin & Pedro P. Corbi. (2016) Crystal structure, spectroscopic characterization and antibacterial activities of a silver complex with sulfameter. Journal of Molecular Structure 1125, pages 609-615.
Crossref
Shafiq Shaikh, Venkata Arun Timmaraju, Jason P. Torres, Kayla M. Socarras, Priyanka A. S. Theophilus & Eva Sapi. (2016) Influence of tick and mammalian physiological temperatures on Borrelia burgdorferi biofilms. Microbiology 162:11, pages 1984-1995.
Crossref
Asher Brauner, Ofer Fridman, Orit Gefen & Nathalie Q. Balaban. (2016) Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nature Reviews Microbiology 14:5, pages 320-330.
Crossref
A. Goc, A. Niedzwiecki & M. Rath. (2015) In vitro evaluation of antibacterial activity of phytochemicals and micronutrients against Borrelia burgdorferi and Borrelia garinii . Journal of Applied Microbiology 119:6, pages 1561-1572.
Crossref
John R. Caskey & Monica E. Embers. (2015) Persister Development by Borrelia burgdorferi Populations In Vitro . Antimicrobial Agents and Chemotherapy 59:10, pages 6288-6295.
Crossref
Jie Feng, Megan Weitner, Wanliang Shi, Shuo Zhang, David Sullivan & Ying Zhang. (2015) Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library. Antibiotics 4:3, pages 397-410.
Crossref
Bijaya Sharma, Autumn V. Brown, Nicole E. Matluck, Linden T. Hu & Kim Lewis. (2015) Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Antimicrobial Agents and Chemotherapy 59:8, pages 4616-4624.
Crossref
Adam DyerGemma BrownLenka StejskalPeter R. LaityRichard J. Bingham. (2015) The Borrelia afzelii outer membrane protein BAPKO_0422 binds human factor-H and is predicted to form a membrane-spanning β-barrel. Bioscience Reports 35:4.
Crossref
Christian Perronne. (2015) Critical review of studies trying to evaluate the treatment of chronic Lyme disease. La Presse Médicale 44:7-8, pages 828-831.
Crossref
John N. Aucott. (2015) Posttreatment Lyme Disease Syndrome. Infectious Disease Clinics of North America 29:2, pages 309-323.
Crossref
Sheila L. Arvikar & Allen C. Steere. (2015) Diagnosis and Treatment of Lyme Arthritis. Infectious Disease Clinics of North America 29:2, pages 269-280.
Crossref
Hongxia Niu, Peng Cui, Wanliang Shi, Shuo Zhang, Jie Feng, Yong Wang, David Sullivan, Wenhong Zhang, Bingdong Zhu & Ying Zhang. (2015) Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library. Antibiotics 4:2, pages 179-187.
Crossref
Alison W. Rebman, Mark J. Soloski & John N. Aucott. 2015. Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Sex and Gender Differences in Infection and Treatments for Infectious Diseases 337 360 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.